Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vulcan Materials
VMC
|
+$180M |
| 2 |
Walmart Inc
WMT
|
+$154M |
| 3 |
McDonald's
MCD
|
+$143M |
| 4 |
Hartford Financial Services
HIG
|
+$143M |
| 5 |
Citigroup
C
|
+$136M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Freeport-McMoran
FCX
|
+$153M |
| 2 |
Advance Auto Parts
AAP
|
+$131M |
| 3 |
Wells Fargo
WFC
|
+$130M |
| 4 |
CTRA
Coterra Energy
CTRA
|
+$116M |
| 5 |
Abbott
ABT
|
+$103M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.64% |
| 2 | Consumer Discretionary | 12.28% |
| 3 | Healthcare | 9.19% |
| 4 | Energy | 8.04% |
| 5 | Technology | 7.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Westlake Corp
WLK
$9.97B
| $10.5M | 0.05% |
158,564
-1,624,344
| -91% | -$103M |
|
477
Atkore
ATKR
$3.17B
| $10.5M | 0.05% |
+397,743
| New | +$10.2M |
|
|
FNSR
478
DELISTED
Finisar Corp
FNSR
| $10.4M | 0.05% |
381,620
-206,240
| -35% | -$6.32M |
|
479
Alnylam Pharmaceuticals
ALNY
$30.8B
| $10.4M | 0.05% |
203,467
-139,355
| -41% | -$6.44M |
|
|
BNY
480
Bank of New York Mellon
BNY
$110B
| $10.4M | 0.05% |
220,363
-1,287,347
| -85% | -$60.2M |
|
481
Voya Financial
VOYA
$8.97B
| $10.3M | 0.05% |
272,367
-415,674
| -60% | -$16.7M |
|
|
RAD
482
DELISTED
Rite Aid Corporation
RAD
| $10.3M | 0.05% |
+121,244
| New | +$14.6M |
|
483
Nektar Therapeutics
NKTR
$2.46B
| $10.3M | 0.05% |
+29,188
| New | +$6.56M |
|
484
TransUnion
TRU
$16.3B
| $10.3M | 0.05% |
267,298
+124,976
| +88% | +$4.39M |
|
485
LyondellBasell Industries
LYB
$21.3B
| $10.1M | 0.05% |
111,195
+105,257
| +1,773% | +$9.61M |
|
486
Shake Shack
SHAK
$3.05B
| $10.1M | 0.05% |
303,500
+269,514
| +793% | +$9.31M |
|
|
ALXN
487
DELISTED
Alexion Pharmaceuticals
ALXN
| $10.1M | 0.05% |
83,159
-130,741
| -61% | -$16.9M |
|
|
CNH
488
CNH Industrial
CNH
$19.3B
| $10.1M | 0.05% |
+1,199,686
| New | +$9.77M |
|
489
Omega Healthcare
OHI
$14.2B
| $10.1M | 0.05% |
304,825
+33,546
| +12% | +$1.08M |
|
|
XLNX
490
DELISTED
Xilinx Inc
XLNX
| $9.99M | 0.05% |
172,588
-393,237
| -69% | -$23.1M |
|
491
Sun Communities
SUI
$15B
| $9.95M | 0.05% |
123,847
+5,828
| +5% | +$464K |
|
492
Centene
CNC
$32.1B
| $9.94M | 0.05% |
279,002
-38,590
| -12% | -$1.29M |
|
|
KLXI
493
DELISTED
KLX Inc.
KLXI
| $9.93M | 0.05% |
263,451
-35,863
| -12% | -$1.45M |
|
494
Principal Financial Group
PFG
$24B
| $9.89M | 0.05% |
156,677
-20,116
| -11% | -$1.23M |
|
|
WPG
495
DELISTED
Washington Prime Group Inc.
WPG
| $9.87M | 0.05% |
126,183
+47,740
| +61% | +$4M |
|
|
SC
496
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
| $9.82M | 0.05% |
737,189
-1,321,194
| -64% | -$18.3M |
|
497
Children's Place
PLCE
$57.6M
| $9.8M | 0.05% |
81,632
-52,772
| -39% | -$5.56M |
|
498
Quest Diagnostics
DGX
$27.1B
| $9.77M | 0.05% |
99,538
-55,295
| -36% | -$5.27M |
|
499
CALL
Viatris
VTRS
$18.7B
| $9.75M | 0.05% |
+250,000
| New | +$10.1M |
|
500
Acuity Brands
AYI
$10.1B
| $9.7M | 0.05% |
47,557
+46,297
| +3,674% | +$9.78M |
|
Similar funds
Dmitry Balyasny's Q1 2017 Portfolio in Review
As of Q1 2017, Dmitry Balyasny held 1,926 positions worth $21.4B, up 15% from $18.6B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Dmitry Balyasny deployed $1.67B of net new capital in Q1 2017, opening 598 new positions and adding to 490 existing holdings. Its largest new stake was Citigroup: 2,292,111 shares worth $137M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Freeport-McMoran, an estimated $153M trimmed.
- Dmitry Balyasny's largest Q1 2017 buy was Citigroup: 2,292,111 shares worth $137M.
- Dmitry Balyasny added most to Vulcan Materials in Q1 2017, an estimated $180M increase.
- Dmitry Balyasny's biggest Q1 2017 reduction was Freeport-McMoran, cutting an estimated $153M.
- Dmitry Balyasny fully exited Coterra Energy in Q1 2017, selling an estimated $116M.
- Dmitry Balyasny's ten largest holdings make up 10% of its $21.4B portfolio in Q1 2017.
- Dmitry Balyasny opened 598 new positions and closed 369 in Q1 2017.
- Dmitry Balyasny's portfolio value rose 15% quarter-over-quarter to $21.4B.
Based on Balyasny Asset Management's 13F filing for Q1 2017, filed 15 May 2017.